Sunday February 16, 2020

BreastCheck benefits need to be examined

Breast screening is fallible, and with potential extra costs due to legal actions, questions about the viability of the programme are invevitable

19th January, 2020
There is debate in some countries as to whether breast screening should be continued at all

Cancer screening aims to reduce the death rate from the disease in society by applying mass-scale, population-based, detection tests to large numbers of healthy, asymptomatic people.

Government-run programmes in Ireland now screen approximately 500,000 citizens annually for cervical, breast and bowel cancer, at a cumulative annual cost of €71 million.

The type of tests that can be deployed on such huge scales must of necessity be relatively quick, simple and affordable. The actual benefit for an...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader



Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.



€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.




90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

Medical product supply chain could face interruption if virus continues to spread

Aaron Rogan | 19 hours ago

Chief executive Paul Reid believes private care should be separate

Daniel Murray | 1 week ago

If an artist in the US can create a credible facial image of a smoker from DNA left on a discarded cigarette butt, imagine the potential power of genomic medicine, the vast awards awaiting those who possess access to genomes, and the potential for misuse where regulation of genetic information is light

Killian Woods | 1 week ago